|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar
|
|
4
|
Jiang WQ, Fu FF, Li YX, Wang WB, Wang HH,
Jiang HP and Teng LS: Molecular biomarkers of colorectal cancer:
prognostic and predictive tools for clinical practice. J Zhejiang
Univ Sci B. 13:663–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Van Cutsem E and Costa F: Progress in the
adjuvant treatment of colon cancer: has it influenced clinical
practice? JAMA. 294:2758–2760. 2005.PubMed/NCBI
|
|
6
|
Longley DB, Allen WL and Johnston PG: Drug
resistance, predictive markers and pharmacogenomics in colorectal
cancer. Biochim Biophys Acta. 1766:184–196. 2006.PubMed/NCBI
|
|
7
|
Lippman SM: The dilemma and promise of
cancer chemoprevention. Nat Clin Pract Oncol. 3:5232006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin L, Liu Y, Li H, Li PK, Fuchs J,
Shibata H, Iwabuchi Y and Lin J: Targeting colon cancer stem cells
using a new curcumin analogue, GO-Y030. Br J Cancer. 105:212–220.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takebe N, Harris PJ, Warren RQ and Ivy SP:
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog
pathways. Nat Rev Clin Oncol. 8:97–106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou BB, Zhang H, Damelin M, Geles KG,
Grindley JC and Dirks PB: Tumour-initiating cells: challenges and
opportunities for anticancer drug discovery. Nat Rev Drug Discov.
8:806–823. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
17
|
Zhou S, Schuetz JD, Bunting KD, Colapietro
AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M,
Nakauchi H and Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is
expressed in a wide variety of stem cells and is a molecular
determinant of the side-population phenotype. Nat Med. 7:1028–1034.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schinkel AH and Jonker JW: Mammalian drug
efflux transporters of the ATP binding cassette (ABC) family: an
overview. Adv Drug Deliv Rev. 55:3–29. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Robey RW, To KK, Polgar O, Dohse M, Fetsch
P, Dean M and Bates SE: ABCG2: a perspective. Adv Drug Deliv Rev.
61:3–13. 2009. View Article : Google Scholar
|
|
20
|
Madjd Z, Mehrjerdi AZ, Sharifi AM,
Molanaei S, Shahzadi SZ and Asadi-Lari M: CD44+ cancer
cells express higher levels of the anti-apoptotic protein Bcl-2 in
breast tumours. Cancer Immun. 9:42009.
|
|
21
|
Carter BZ, Qiu Y, Huang X, Diao L, Zhang
N, Coombes KR, Mak DH, Konopleva M, Cortes J, Kantarjian HM, Mills
GB, Andreeff M and Kornblau SM: Survivin is highly expressed in
CD34(+)38(−) leukemic stem/progenitor cells and predicts poor
clinical outcomes in AML. Blood. 120:173–180. 2012.
|
|
22
|
Terpstra W, Ploemacher RE, Prins A, van
Lom K, Pouwels K, Wognum AW, Wagemaker G, Löwenberg B and Wielenga
JJ: Fluorouracil selectively spares acute myeloid leukemia cells
with long-term growth abilities in immunodeficient mice and in
culture. Blood. 88:1944–1950. 1996.PubMed/NCBI
|
|
23
|
Paterson SC, Smith KD, Holyoake TL and
Jørgensen JHG: Is there a cloud in the silver lining for imatinib?
Br J Cancer. 88:983–987. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ji HF, Li XJ and Zhang HY: Natural
products and drug discovery. Can thousands of years of ancient
medical knowledge lead us to new and powerful drug combinations in
the fight against cancer and dementia? EMBO Rep. 10:194–200.
2009.PubMed/NCBI
|
|
26
|
Chinese Pharmacopoeia Commission.
Pharmacopoeia of the Peoples Republic of China. 1. Chinese Medical
Science and Technology Press; Beijing: pp. 573–575. 2010, (In
Chinese).
|
|
27
|
Xu YY and Yu EX: Clinical analysis of the
effect of Pien Tze Huang in treatment of 42 patients with moderate
or advanced liver cancer. Shanghai J Tradit Chin Med (Chin).
12:4–5. 1994.(In Chinese).
|
|
28
|
Gu ZX: Therapeutical observation of
advanced colon cancer. Chin Tradit Patent Med (Chin). 15:231993.(In
Chinese).
|
|
29
|
Liu CS: Review of pharmacology and
clinical application of Pien Tze Huang. Med Pharm World (Chin).
7:64–66. 2006.(In Chinese).
|
|
30
|
Lin JM, Wei LH, Chen YQ, Liu XX, Hong ZF,
Sferra TJ and Peng J: Pien Tze Huang-induced apoptosis in human
colon cancer HT-29 cells is associated with regulation of the Bcl-2
family and activation of caspase 3. Chin J Integr Med. 17:685–690.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhuang QC, Hong F, Shen AL, Zheng LP, Zeng
JW, Lin W, Chen YQ, Sferra TJ, Hong ZF and Peng J: Pien Tze Huang
inhibits tumor cell proliferation and promotes apoptosis via
suppressing the STAT3 pathway in colorectal cancer mouse. Int J
Oncol. 40:1569–1574. 2012.PubMed/NCBI
|
|
32
|
Shen AL, Hong F, Liu LY, Lin JM, Zhuang
QC, Hong ZF and Peng J: Effects of Pien Tze Huang on angiogenesis
in vivo and in vitro. Chin J Integr Med. 18:431–436. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shen AL, Hong F, Liu LY, Lin JM, Wei LH,
Cai QY, Hong ZF and Peng J: Pien Tze Huang inhibits the
proliferation of human colon carcinoma cells by arresting G1/S cell
cycle progression. Oncol Lett. 4:767–770. 2012.PubMed/NCBI
|
|
34
|
Shen AL, Chen YQ, Hong F, Lin JM, Wei LH,
Hong ZF, Sferra TJ and Peng J: Pien Tze Huang suppresses
IL-6-inducible STAT3 activation in human colon carcinoma cells
through induction of SOCS3. Oncol Rep. 28:2125–2130.
2012.PubMed/NCBI
|
|
35
|
Shen A, Lin J, Chen Y, Lin W, Liu L, Hong
Z, Sferra TJ and Peng J: Pien Tze Huang inhibits tumor angiogenesis
in a mouse model of colorectal cancer via suppression of multiple
cellular pathways. Oncol Rep. 30:1701–1706. 2013.PubMed/NCBI
|
|
36
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Golebiewska A, Brons NH, Bjerkvig R and
Niclou SP: Critical appraisal of the side population assay in stem
cell and cancer stem cell research. Cell Stem Cell. 8:136–147.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bleau AM, Hambardzumyan D, Ozawa T,
Fomchenko EI, Huse JT, Brennan CW and Holland EC: PTEN/PI3K/Akt
pathway regulates the side population phenotype and ABCG2 activity
in glioma tumor stem-like cells. Cell Stem Cell. 4:226–235. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chua C, Zaiden N, Chong KH, See SJ, Wong
MC, Ang BT and Tang C: Characterization of a side population of
astrocytoma cells in response to temozolomide. J Neurosurg.
109:856–866. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cells. 24:506–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mitsutake N, Iwao A, Nagai K, Namba H,
Ohtsuru A, Saenko V and Yamashita S: Characterization of side
population in thyroid cancer cell lines: cancer stem-like cells are
enriched partly but not exclusively. Endocrinology. 148:1797–1803.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side
population is enriched in tumorigenic, stem-like cancer cells,
whereas ABCG2+ and ABCG2− cancer cells are
similarly tumorigenic. Cancer Res. 65:6207–6219. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu C and Alman BA: Side population cells
in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar
|
|
46
|
Wu C, Wei Q, Utomo V, Nadesan P, Whetstone
H, Kandel R, Wunder JS and Alman BA: Side population cells isolated
from mesenchymal neoplasms have tumor initiating potential. Cancer
Res. 67:8216–8222. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Efferth T: Stem cells, cancer stem-like
cells, and natural products. Planta Med. 78:935–942. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Weber DA, Wheat JM and Currie GM: Cancer
stem cells and the impact of Chinese herbs, isolates and other
complementary medical botanicals: a review. Zhong Xi Yi Jie He Xue
Bao. 10:493–503. 2012. View Article : Google Scholar : PubMed/NCBI
|
